{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:55:02Z","timestamp":1778820902178,"version":"3.51.4"},"reference-count":114,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T00:00:00Z","timestamp":1557705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijwd.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T06:00:39Z","timestamp":1558159239000},"page":"235-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of keratinocyte carcinoma - Special considerations in the elderly"],"prefix":"10.1097","volume":"5","author":[{"given":"Alison","family":"Bailey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Vasicek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Janeczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andia","family":"Mitri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"7","key":"10.1016\/j.ijwd.2019.05.005_bb0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.0906-6705.2004.00181.x","article-title":"Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: A pilot study","volume":"13","author":"Ahmadi","year":"2004","journal-title":"Exp Dermatol"},{"issue":"8","key":"10.1016\/j.ijwd.2019.05.005_bb0010","first-page":"1091","article-title":"Controversies in perioperative management of blood thinners in dermatologic surgery: Continue or discontinue?","volume":"30","author":"Alcalay","year":"2004","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.brachy.2017.06.011","article-title":"Dose comparison between TG-43-based calculations and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions","volume":"16","author":"Aldelaijan","year":"2017","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamadermatol.2013.7444","article-title":"The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome","volume":"150","author":"Ally","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.ijwd.2019.05.005_bb0025","first-page":"2365","article-title":"Cryosurgery for common skin conditions","volume":"69","author":"Andrews","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0030","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: A single blind, non-inferiority, randomized controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0035","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.clindermatol.2013.08.020","article-title":"Non-melanoma skin cancers: Photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies","volume":"31","author":"Bahner","year":"2013","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5114\/jcb.2017.68191","article-title":"Two years results of electronic brachytherapy for basal cell carcinoma","volume":"9","author":"Ballester-S\u00e1nchez","year":"2017","journal-title":"J Contemp Brachytherapy"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0045","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaad.2006.01.041","article-title":"Treatment of basal cell carcinoma with curettage alone","volume":"54","author":"Barlow","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0055","first-page":"222","article-title":"Basal cell carcinoma of the skin with mixed histomorphology: A comparative study","volume":"52","author":"Barto\u0161","year":"2016","journal-title":"Cesk Patol"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0060","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejca.2017.08.022","article-title":"Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial","volume":"86","author":"Basset-S\u00e9guin","year":"2017","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): A multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2017.07.031","article-title":"A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management","volume":"78","author":"Baum","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamadermatol.2016.5268","article-title":"Comparison of physical pretreatment regimens to enhance protoporphyrin IX uptake in photodynamic therapy: A randomized clinical trial","volume":"153","author":"Bay","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jamadermatol.2016.5058","article-title":"A novel alternate dosing of vismodegib for treatment of patients with advanced basal cell carcinomas","volume":"153","author":"Becker","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-0960.2004.00060.x","article-title":"Imiquimod: Potential risk of an immunostimulant","volume":"45","author":"Benson","year":"2004","journal-title":"Australas J Dermatol"},{"issue":"11","key":"10.1016\/j.ijwd.2019.05.005_bb0090","first-page":"16","article-title":"High-dose rate electronic brachytherapy: A nonsurgical treatment alternative for nonmelanoma skin cancer","volume":"9","author":"Bhatnagar","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0095","author":"Bichakjian"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0100","author":"Bichakjian"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1684\/ejd.2017.3209","article-title":"Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases","volume":"28","author":"Blum","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0110","series-title":"Surgery of the Skin","first-page":"134","article-title":"Electrosurgery","author":"Bolotin","year":"2015"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus","volume":"56","author":"Braathen","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13555-016-0120-y","article-title":"Acute and chronic cutaneous reactions to ionizing radiation therapy","volume":"6","author":"Bray","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0125","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40257-014-0085-5","article-title":"Optimal management of skin cancer in immunosuppressed patients","volume":"15","author":"Brin","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/0253-7613.161249","article-title":"Imiquimod \u2013 Its role in the treatment of cutaneous malignancies","volume":"47","author":"Bubna","year":"2015","journal-title":"Indian J Pharmacol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0135","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1529-8019.2012.01454.x","article-title":"Hemorrhagic complications in dermatologic surgery","volume":"24","author":"Bunick","year":"2011","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.ijwd.2019.05.005_bb0140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1524-4725.2012.02490.x","article-title":"The management of antithrombotic medication in skin surgery","volume":"38","author":"Callahan","year":"2012","journal-title":"Dermatol Surg"},{"issue":"9","key":"10.1016\/j.ijwd.2019.05.005_bb0145","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/dsu.12300","article-title":"Topical and intralesional treatment of nonmelanoma skin cancer: Efficacy and cost comparisons","volume":"39","author":"Chitwood","year":"2013","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0150","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.jid.5700740","article-title":"Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma","volume":"127","author":"Chren","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0155","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jid.2012.403","article-title":"Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma","volume":"133","author":"Chren","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1200\/JCO.2005.02.155","article-title":"Mortality risk from squamous cell skin cancer","volume":"23","author":"Clayman","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.det.2016.02.011","article-title":"Practice and educational gaps in radiation therapy in dermatology","volume":"34","author":"Cognetta","year":"2016","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.ijwd.2019.05.005_bb0170","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cancers8100090","article-title":"Photodynamic therapy for non-melanoma skin cancers","volume":"8","author":"Cohen","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archderm.139.2.143","article-title":"A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery","volume":"139","author":"Cook","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ad.2017.08.003","article-title":"Correlation between incisional biopsy histological subtype and a Mohs surgery specimen for nonmelanoma skin cancer","volume":"109","author":"Cort\u00e9s-Peralta","year":"2018","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.fsc.2009.06.001","article-title":"Mohs micrographic surgery for the management of nonmelanoma skin cancers","volume":"17","author":"Cumberland","year":"2009","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0190","first-page":"E16","article-title":"Electronic brachytherapy and superficial radiation therapy: Will you be adding it to your practice?","volume":"92","author":"David","year":"2013","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5114\/jcb.2016.64112","article-title":"Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature","volume":"8","author":"Delishaj","year":"2016","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0200","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2133.2005.06799.x","article-title":"Skin cancer incidence and the ageing population","volume":"153","author":"Diffey","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0205","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.currproblcancer.2015.07.001","article-title":"A comprehensive guide to the surgical management of nonmelanoma skin cancer","volume":"39","author":"Divine","year":"2015","journal-title":"Curr Probl Cancer"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(17)30072-4","article-title":"Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): A randomised, regimen-controlled, double-blind, phase 2 trial","volume":"18","author":"Dr\u00e9no","year":"2017","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ijwd.2019.05.005_bb0215","first-page":"670","article-title":"Vismodegib (erivedge) for advanced Basal cell carcinoma","volume":"37","author":"Fellner","year":"2012","journal-title":"P T"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0220","first-page":"15","article-title":"Photodynamic therapy\u2014Aspects of pain management","volume":"13","author":"Fink","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0225","series-title":"Dermatology","first-page":"2263","article-title":"Other topical medications","author":"Fox","year":"2018"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0230","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaad.2014.06.038","article-title":"Patient-reported outcomes of electrodessication & curettage for treatment of non-melanoma skin cancer","volume":"71","author":"Galles","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.14336\/AD.2017.0503","article-title":"Cancer epidemics in the elderly as an emerging issue in geriatric oncology","volume":"8","author":"Garcovich","year":"2017","journal-title":"Aging Dis"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0240","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"50","author":"Geisse","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000183753","article-title":"Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy","volume":"218","author":"Gerritsen","year":"2009","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0250","doi-asserted-by":"crossref","first-page":"476","DOI":"10.5301\/ejo.5000405","article-title":"Outcome of 110 basal cell carcinomas of the eyelid treated with frozen section-controlled excision: Mean follow-up over 5 years","volume":"24","author":"Giordano Resti","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0255","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2015.04.050","article-title":"Acute pain management in dermatology: Risk assessment and treatment","volume":"73","author":"Glass","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0260","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2014.01.849","article-title":"The ethical implications of \"more than one way to skin a cat\": Increasing use of radiation therapy to treat nonmelanoma skin cancers by dermatologists","volume":"70","author":"Grant-Kels","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0022034509359125","article-title":"Factors affecting wound healing","volume":"89","author":"Guo","year":"2010","journal-title":"J Dent Res"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0270","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2011.01.004","article-title":"The role of radiation therapy in the management of skin cancers","volume":"29","author":"Hulyalkar","year":"2011","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0275","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bjd.14843","article-title":"Safety, complications and patients' acceptance of Mohs micrographic surgery under local anaesthesia: Results from the U.K. MAPS (Mohs Acceptance and Patient Safety) Collaboration Group","volume":"176","author":"Hussain","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.05.005_bb9100","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1524-4725.2010.01747.x","article-title":"Prevalence of Underdiagnosed Aggressive Non-Melanoma Skin Cancers Treated with Mohs Micrographic Surgery: Analysis of 513 Cases.","volume":"36","author":"Izikson","year":"2010","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0280","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/COC.0000000000000088","article-title":"Systemic therapy in advanced cutaneous squamous cell carcinoma (CSCC): The Roswell Park Experience and a review of the literature","volume":"39","author":"Jarkowski","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jgo.2016.03.008","article-title":"Adding active surveillance as a treatment option for low risk cancers in patients with limited life expectancy","volume":"7","author":"Jung","year":"2016","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0290","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0295","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/DSS.0000000000000296","article-title":"Consensus for nonmelanoma skin cancer treatment: Basal cell carcinoma, including a cost analysis of treatment methods","volume":"41","author":"Kauvar","year":"2015","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.ijwd.2019.05.005_bb0300","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/DSS.0000000000000478","article-title":"Consensus for nonmelanoma skin cancer treatment, part II: Squamous cell carcinoma, including a cost analysis of treatment methods","volume":"41","author":"Kauvar","year":"2015","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0305","first-page":"170","article-title":"The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig applicator)","volume":"175","author":"Kohler-Brock","year":"1999","journal-title":"Strahlenther Onkol"},{"issue":"7","key":"10.1016\/j.ijwd.2019.05.005_bb0310","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00105-007-1363-4","article-title":"Side effects of topical photodynamic therapy","volume":"58","author":"Lehmann","year":"2007","journal-title":"Hautarzt"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaad.2005.02.059","article-title":"Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I: Experience over 10 years","volume":"53","author":"Leibovitch","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0320","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/571734","article-title":"Nonsurgical treatment options for basal cell carcinoma","volume":"2011","author":"Lien","year":"2011","journal-title":"J Skin Cancer"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0325","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamainternmed.2013.639","article-title":"Treatment of nonfatal conditions at the end of life: Nonmelanoma skin cancer","volume":"173","author":"Linos","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0330","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0360-3016(01)01656-X","article-title":"Radiotherapy for epithelial skin cancer","volume":"51","author":"Locke","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ijwd.2019.05.005_bb0335","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/archdermatol.2009.291","article-title":"Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: A systematic review","volume":"145","author":"Love","year":"2009","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.ijwd.2019.05.005_bb0340","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jdcr.2018.03.015","article-title":"Dehydrated human amnion\/chorion membrane allograft as an aid for wound healing in patients with full-thickness scalp defects after Mohs micrographic surgery","volume":"4","author":"Lyons","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0345","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1067\/mjd.2001.111335","article-title":"Imiquimod 5% cream in the treatment of Bowen's disease","volume":"44","author":"Mackenzie-Wood","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0350","first-page":"167","article-title":"Basal cell carcinoma: Pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management","volume":"88","author":"Marzuka","year":"2015","journal-title":"Yale J Biol Med"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0360","first-page":"50","article-title":"Photodynamic therapy in the treatment of basal cell carcinoma","volume":"6","author":"Matei","year":"2013","journal-title":"J Med Life"},{"issue":"10","key":"10.1016\/j.ijwd.2019.05.005_bb0365","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.oraloncology.2012.02.015","article-title":"Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion","volume":"48","author":"Mendenhall","year":"2012","journal-title":"Oral Oncol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0370","doi-asserted-by":"crossref","first-page":"979.e1-12","DOI":"10.1016\/j.jaad.2013.12.045","article-title":"Topical pharmacotherapy for skin cancer Part II. Clinical applications","volume":"70","author":"Micali","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0375","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: A population-based study in Olmsted County, Minnesota, 2000 to 2019","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.ijwd.2019.05.005_bb0380","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ncponc0883","article-title":"Management of nonmelanoma skin cancer in 2007","volume":"4","author":"Neville","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0385","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.brachy.2018.01.002","article-title":"Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions","volume":"17","author":"Olek","year":"2018","journal-title":"Brachytherapy"},{"issue":"7","key":"10.1016\/j.ijwd.2019.05.005_bb0390","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/DSS.0000000000000800","article-title":"Photodynamic therapy: A clinical consensus guide","volume":"42","author":"Ozog","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0395","doi-asserted-by":"crossref","first-page":"70","DOI":"10.12703\/P6-70","article-title":"Advances in the management of cutaneous squamous cell carcinoma","volume":"6","author":"Parikh","year":"2014","journal-title":"F1000Prime Rep"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0400","first-page":"1","article-title":"A novel purse-string suture and dehydrated human amnion\/chorion membrane allograft closure technique for the repair of defects following Mohs micrographic and excisional surgery","volume":"4","author":"Park","year":"2016","journal-title":"J Clin Investigat Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0405","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5114\/jcb.2017.68480","article-title":"Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: A matched pair cohort study","volume":"9","author":"Patel","year":"2017","journal-title":"J Contemp Brachytherapy"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0410","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jaad.2006.04.004","article-title":"Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma","volume":"55","author":"Peris","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0415","author":"Prickett"},{"issue":"7","key":"10.1016\/j.ijwd.2019.05.005_bb0420","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12094-014-1272-9","article-title":"Management of high-risk and advanced basal cell carcinoma","volume":"17","author":"Puig","year":"2015","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0425","first-page":"318","article-title":"Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: Results of a prospective 5-year study","volume":"85","author":"Quirk","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0430","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/CCID.S3507","article-title":"Management of superficial basal cell carcinoma: Focus on imiquimod","volume":"2","author":"Raasch","year":"2009","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0435","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0560.2009.01340.x","article-title":"Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer","volume":"37","author":"Reiger","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0440","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.det.2014.03.009","article-title":"Photodynamic therapy","volume":"32","author":"Rkein","year":"2014","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.ijwd.2019.05.005_bb0445","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0450","first-page":"427","article-title":"Treatment of Bowen's disease with topical 5% imiquimod cream: Retrospective study","volume":"33","author":"Rosen","year":"2007","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0455","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0460","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/08998280.2017.11929637","article-title":"Acute exacerbation of myasthenia gravis with topical imiquimod use","volume":"30","author":"Saad","year":"2017","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0465","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.94323","article-title":"Nonmelanoma skin cancer","volume":"5","author":"Samarasinghe","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0470","first-page":"357","article-title":"Cryosurgery for facial and scalp lesions of basal cell carcinoma: A study in 29 elderly patients","volume":"15","author":"Savant","year":"2017","journal-title":"Skinmed"},{"issue":"10","key":"10.1016\/j.ijwd.2019.05.005_bb0475","doi-asserted-by":"crossref","first-page":"23300","DOI":"10.3390\/ijms161023300","article-title":"Usefulness of photodynamic therapy as a possible therapeutic alternative in the treatment of basal cell carcinoma","volume":"16","author":"Savoia","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"6 Pt 1","key":"10.1016\/j.ijwd.2019.05.005_bb0480","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/0190-9622(90)70344-H","article-title":"Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms","volume":"23","author":"Sexton","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0485","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1440-0960.2000.00383.x","article-title":"Curettage, electrosurgery and skin cancer","volume":"41","author":"Sheridan","year":"2000","journal-title":"Australian J Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0490","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0190-9622(98)70405-0","article-title":"Mohs micrographic surgery","volume":"39","author":"Shriner","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0495","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.2004.06047.x","article-title":"Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--Results of a retrospective study and review of the literature","volume":"151","author":"Smeets","year":"2004","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0500","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/lsm.20606","article-title":"Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma","volume":"40","author":"Smucler","year":"2008","journal-title":"Lasers Surg Med"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0505","first-page":"194","article-title":"Optimized photodynamic therapy with systemic photosensitizer following debulking technique for nonmelanoma skin cancers","volume":"33","author":"Souza","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ijwd.2019.05.005_bb0510","series-title":"Dermatology","first-page":"1872","article-title":"Actinic keratosis, basal cell carcinoma, and squamous cell carcinoma","author":"Soyer","year":"2018"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1753-4887.2011.00444.x","article-title":"Anticoagulant activity of select dietary supplements","volume":"70","author":"Stanger","year":"2012","journal-title":"Nutr Rev"},{"issue":"6","key":"10.1016\/j.ijwd.2019.05.005_bb0520","first-page":"454","article-title":"Photodynamic therapy in dermatology","volume":"8","author":"Steinbauer","year":"2010","journal-title":"J Dtsch Dematol Ges"},{"issue":"4","key":"10.1016\/j.ijwd.2019.05.005_bb0525","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","article-title":"Risk factors for cutaneous squamous cell carcinoma outcomes: A systemic review and meta-analysis","volume":"152","author":"Thompson","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0530","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5114\/jcb.2014.43247","article-title":"Non-melanoma skin cancer treated with HDR Valencia applicator: Clinical outcomes","volume":"6","author":"Tormo","year":"2014","journal-title":"J Contemp Brachytherapy"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0535","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamadermatol.2016.3884","article-title":"Follow-up on programmed cell death 1 inhibitor for cutaneous squamous cell carcinoma","volume":"153","author":"Tran","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0540","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21037\/apm.2016.11.10","article-title":"Palliative radiotherapy for skin malignancies","volume":"6","author":"Vuong","year":"2017","journal-title":"Ann Palliat Med"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0545","first-page":"447","article-title":"Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy","volume":"7","author":"Warshauer","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.05.005_bb0550","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/000155599750010292","article-title":"Five-year results of Mohs micrographic surgery for aggressive facial basal cell carcinoma in Sweden","volume":"79","author":"Wennberg","year":"1999","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0555","first-page":"241","article-title":"Dermatologic surgery in the demented patient","volume":"29","author":"Whitely","year":"2003","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.ijwd.2019.05.005_bb0565","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-0960.2004.00030.x","article-title":"Psoriasis induced by topical imiquimod","volume":"45","author":"Wu","year":"2004","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.05.005_bb0570","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2017.04.1108","article-title":"Efficacy of curettage alone for invasive cutaneous squamous cell carcinoma: A retrospective cohort study","volume":"77","author":"Yakish","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.05.005_bb0575","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamadermatol.2015.3210","article-title":"Intermittent vismodegib therapy in basal cell nevus syndrome","volume":"152","author":"Yang","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.ijwd.2019.05.005_bb0580","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00105-015-3703-0","article-title":"Cryosurgery in dermatology","volume":"66","author":"Zouboulis","year":"2015","journal-title":"Hautarzt"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T05:58:47Z","timestamp":1721282327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647519300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2352647519300462"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.05.005","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of keratinocyte carcinoma - Special considerations in the elderly","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}